MoonLake Stock (NASDAQ:MLTX), Quotes and News Summary

Q: What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MoonLake Stock (NASDAQ: MLTX) stock price, news, charts, stock research, profile.

Open	$43.950
Close	-
Volume / Avg.	48.681K / 465.246K
Day Range	41.920 - 44.000
52 Wk Range	24.000 - 64.980
Market Cap	$2.667B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	28.12%
Days to Cover	18.56

Recent News

Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?

Results with MoonLake Immunotherapeutics' Nanobody sonelokimab in Psoriatic Arthritis. Achieve over 60% ACR50, 40% ACR70, and 80% PASI90 by week 24. Unprecedented improvements compared to competitors.

Vandana Singh

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Avi Kapoor

Dow Turns Lower; EchoStar Shares Plunge

U.S. stocks turned lower toward the end of trading, with the Dow Jones falling around 50 points on Monday The Dow traded down 0.16% to 34,007.81 while the NASDAQ fell 0.08% to 13,467.42. The S&P 500 also fell, dropping, 0.13% to 4,352.49.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MoonLake (MLTX) stock?

You can purchase shares of MoonLake (NASDAQ: MLTX) through any online brokerage.

View our list of the best stock brokerages.

Who are MoonLake's (MLTX) competitors?

Other companies in MoonLake’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the target price for MoonLake (MLTX) stock?

The latest price target for MoonLake (NASDAQ: MLTX) was reported by Needham on Wednesday, May 8, 2024. The analyst firm set a price target for 66.00 expecting MLTX to rise to within 12 months (a possible 55.62% upside). 46 analyst firms have reported ratings in the last year.

Current Stock Price for MoonLake (MLTX)?

The stock price for MoonLake (NASDAQ: MLTX) is $42.41 last updated Today at May 8, 2024 at 12:25 PM EDT.

Does MoonLake (MLTX) pay a dividend?

There are no upcoming dividends for MoonLake.

When is MoonLake (NASDAQ:MLTX) reporting earnings?

MoonLake’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is MoonLake (MLTX) going to split?

There is no upcoming split for MoonLake.

What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-